Plasmid DNA Strategy as a Starting Material for mRNA Pharmaceuticals
Time: 3:00 pm
day: Day Two
Details:
- Evolution of industry understanding of regulatory expectation
- Understanding phase appropriateness of manufactured DNA
- Unravelling the ongoing global strategy discussion
Speakers:
